S62I (p.Ser62Ile) variant of APOB (Apolipoprotein B-100)
S62I (p.Ser62Ile) in APOB (Apolipoprotein B-100) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The record also includes variant effect predictions and structural context.
S62I (p.Ser62Ile) variant details
- p.Ser62Ile
- NCI-TCGA TCGA novel
- Variant assessed as somatic; moderate impact.
- Missense
- MetaLR 0.22
- MetaSVM -0.65
- SIFT 0.00
- UniProt: Variant assessed as somatic; moderate impact.
- Structural context available